share_log

Maxim Group Maintains Buy on Augmedix, Lowers Price Target to $5

Benzinga ·  Mar 19 10:15

Maxim Group analyst Allen Klee maintains Augmedix (NASDAQ:AUGX) with a Buy and lowers the price target from $6.5 to $5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment